Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Dragojevic S, Ryu JS, Hall ME, Raucher D. Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity. Molecules. 2022 May 24;27(11). doi: 10.3390/molecules27113371. PubMed PMID: 35684309; PubMed Central PMCID: PMC9182553.
Dragojevic S, Turner L, Raucher D. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery. Int J Mol Sci. 2022 Feb 19;23(4). doi: 10.3390/ijms23042301. PubMed PMID: 35216417; PubMed Central PMCID: PMC8878013.
Thomas E, Dragojevic S, Price A, Raucher D. Thermally Targeted p50 Peptide Inhibits Proliferation and Induces Apoptosis of Breast Cancer Cell Lines. Macromol Biosci. 2020 Oct;20(10):e2000170. doi: 10.1002/mabi.202000170. Epub 2020 Jul 30. PubMed PMID: 32734662; PubMed Central PMCID: PMC7737380.
Das P, Boone S, Mitra D, Turner L, Tandon R, Raucher D, Hamme AT 2nd. Synthesis and biological evaluation of fluoro-substituted spiro-isoxazolines as potential anti-viral and anti-cancer agents. RSC Adv. 2020 Aug 10;10(50):30223-30237. doi: 10.1039/d0ra06148d. eCollection 2020 Aug 10. PubMed PMID: 35518245; PubMed Central PMCID: PMC9056317.
Dragojevic S, Mackey R, Raucher D. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma. Molecules. 2019 Sep 6;24(18). doi: 10.3390/molecules24183242. PubMed PMID: 31489879; PubMed Central PMCID: PMC6767252.
Raucher D. Tumor targeting peptides: novel therapeutic strategies in glioblastoma. Curr Opin Pharmacol. 2019 Aug;47:14-19. doi: 10.1016/j.coph.2019.01.006. Epub 2019 Feb 15. Review. PubMed PMID: 30776641; PubMed Central PMCID: PMC7288394.
Das P, Hasan MH, Mitra D, Bollavarapu R, Valente EJ, Tandon R, Raucher D, Hamme AT 2nd. Design, Synthesis, and Preliminary Studies of Spiro-isoxazoline-peroxides against Human Cytomegalovirus and Glioblastoma ∥. J Org Chem. 2019 Jun 7;84(11):6992-7006. doi: 10.1021/acs.joc.9b00746. Epub 2019 May 17. PubMed PMID: 31066280.
Opačak-Bernardi T, Ryu JS, Raucher D. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. J Drug Target. 2017 Jul;25(6):523-531. doi: 10.1080/1061186X.2017.1289537. Epub 2017 Feb 23. PubMed PMID: 28140690.
Dragojevic S, Ryu JS, Raucher D. Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy. Molecules. 2015 Dec 4;20(12):21750-69. doi: 10.3390/molecules201219804. Review. PubMed PMID: 26690101; PubMed Central PMCID: PMC6331894.
Raucher D, Ryu JS. Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol Med. 2015 Sep;21(9):560-70. doi: 10.1016/j.molmed.2015.06.005. Epub 2015 Jul 15. Review. PubMed PMID: 26186888.
Ryu JS, Raucher D. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications. Expert Opin Drug Deliv. 2015 Apr;12(4):653-67. doi: 10.1517/17425247.2015.974546. Epub 2014 Oct 28. Review. PubMed PMID: 25350837.
Das P, Omollo AO, Sitole LJ, McClendon E, Valente EJ, Raucher D, Walker LR, Hamme AT 2nd. Synthesis and Investigation of Novel Spiro-isoxazolines as Anti-Cancer Agents. Tetrahedron Lett. 2015 Apr 1;56(14):1794-1797. doi: 10.1016/j.tetlet.2015.02.059. PubMed PMID: 25821250; PubMed Central PMCID: PMC4371604.
Walker LR, Ryu JS, Perkins E, McNally LR, Raucher D. Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer. Drug Des Devel Ther. 2014;8:1649-58. doi: 10.2147/DDDT.S60451. eCollection 2014. PubMed PMID: 25336913; PubMed Central PMCID: PMC4199967.
Hearst SM, Shao Q, Lopez M, Raucher D, Vig PJ. The design and delivery of a PKA inhibitory polypeptide to treat SCA1. J Neurochem. 2014 Oct;131(1):101-14. doi: 10.1111/jnc.12782. Epub 2014 Jun 23. PubMed PMID: 24903464.
Hearst SM, Shao Q, Lopez M, Raucher D, Vig PJ. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model. Cerebellum. 2014 Oct;13(5):596-606. doi: 10.1007/s12311-014-0576-1. PubMed PMID: 24930030.
Ryu JS, Raucher D. Elastin-like polypeptides: the influence of its molecular weight on local hyperthermia-induced tumor accumulation. Eur J Pharm Biopharm. 2014 Oct;88(2):382-9. doi: 10.1016/j.ejpb.2014.05.016. Epub 2014 May 24. PubMed PMID: 24866938; NIHMSID:NIHMS599216.
Ryu JS, Raucher D. Anti-tumor efficacy of a therapeutic peptide based on thermo-responsive elastin-like polypeptide in combination with gemcitabine. Cancer Lett. 2014 Jun 28;348(1-2):177-84. doi: 10.1016/j.canlet.2014.03.021. Epub 2014 Mar 26. PubMed PMID: 24680816.
Ryu JS, Kuna M, Raucher D. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics. Ther Deliv. 2014 Apr;5(4):429-45. doi: 10.4155/tde.14.14. Review. PubMed PMID: 24856169.
Lyons DF, Le V, Kramer WH, Bidwell GL 3rd, Lewis EA, Raucher D, Correia JJ. Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP[V5G3A2-150]. Biochemistry. 2014 Feb 18;53(6):1081-91. doi: 10.1021/bi400955w. Epub 2014 Feb 4. PubMed PMID: 24450599; PubMed Central PMCID: PMC3985474.
Mikecin AM, Walker LR, Kuna M, Raucher D. Thermally targeted p21 peptide enhances bortezomib cytotoxicity in androgen-independent prostate cancer cell lines. Anticancer Drugs. 2014 Feb;25(2):189-99. doi: 10.1097/CAD.0000000000000036. PubMed PMID: 24113592; PubMed Central PMCID: PMC3915535.
Lyons DF, Le V, Bidwell GL 3rd, Kramer WH, Lewis EA, Raucher D, Correia JJ. Structural and hydrodynamic analysis of a novel drug delivery vector: ELP[V5G3A2-150]. Biophys J. 2013 May 7;104(9):2009-21. doi: 10.1016/j.bpj.2013.03.040. PubMed PMID: 23663844; PubMed Central PMCID: PMC3647178.
Bidwell GL 3rd, Perkins E, Hughes J, Khan M, James JR, Raucher D. Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS One. 2013;8(1):e55104. doi: 10.1371/journal.pone.0055104. Epub 2013 Jan 25. PubMed PMID: 23372821; PubMed Central PMCID: PMC3555869.
Walker L, Perkins E, Kratz F, Raucher D. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. Int J Pharm. 2012 Oct 15;436(1-2):825-32. doi: 10.1016/j.ijpharm.2012.07.043. Epub 2012 Jul 28. PubMed PMID: 22850291; PubMed Central PMCID: PMC3465682.
Moktan S, Raucher D. Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides. Int J Pept Res Ther. 2012 Sep;18(3):227-237. doi: 10.1007/s10989-012-9295-y. PubMed PMID: 23105921; PubMed Central PMCID: PMC3480076.
Moktan S, Perkins E, Kratz F, Raucher D. Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo. Mol Cancer Ther. 2012 Jul;11(7):1547-56. doi: 10.1158/1535-7163.MCT-11-0998. Epub 2012 Apr 24. PubMed PMID: 22532601; PubMed Central PMCID: PMC3392364.
Bidwell GL 3rd, Perkins E, Raucher D. A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth. Cancer Lett. 2012 Jun 28;319(2):136-143. doi: 10.1016/j.canlet.2011.12.042. Epub 2012 Jan 17. PubMed PMID: 22261328; PubMed Central PMCID: PMC3536021.
Moktan S, Ryppa C, Kratz F, Raucher D. A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis. Invest New Drugs. 2012 Feb;30(1):236-48. doi: 10.1007/s10637-010-9560-x. Epub 2010 Oct 12. PubMed PMID: 20938714.
Hearst SM, Walker LR, Shao Q, Lopez M, Raucher D, Vig PJ. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration. Neuroscience. 2011 Dec 1;197:369-80. doi: 10.1016/j.neuroscience.2011.09.025. Epub 2011 Sep 17. PubMed PMID: 21958864; PubMed Central PMCID: PMC3210406.
Bidwell GL 3rd, Raucher D. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv Drug Deliv Rev. 2010 Dec 30;62(15):1486-96. doi: 10.1016/j.addr.2010.05.003. Epub 2010 May 15. Review. PubMed PMID: 20478348; PubMed Central PMCID: PMC2964383.
Bidwell GL 3rd, Whittom AA, Thomas E, Lyons D, Hebert MD, Raucher D. A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation. Peptides. 2010 May;31(5):834-41. doi: 10.1016/j.peptides.2010.02.007. Epub 2010 Feb 16. PubMed PMID: 20167239; PubMed Central PMCID: PMC2872552.
Massodi I, Moktan S, Rawat A, Bidwell GL 3rd, Raucher D. Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. Int J Cancer. 2010 Jan 15;126(2):533-44. doi: 10.1002/ijc.24725. PubMed PMID: 19588502; PubMed Central PMCID: PMC2795124.
Raucher D, Moktan S, Massodi I, Bidwell GL 3rd. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides. Expert Opin Drug Deliv. 2009 Oct;6(10):1049-64. doi: 10.1517/17425240903158909. Review. PubMed PMID: 19743895.
Bidwell GL 3rd, Raucher D. Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades. Expert Opin Drug Deliv. 2009 Oct;6(10):1033-47. doi: 10.1517/17425240903143745. Review. PubMed PMID: 19637980.
Massodi I, Thomas E, Raucher D. Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules. 2009 Jun 4;14(6):1999-2015. doi: 10.3390/molecules14061999. PubMed PMID: 19513001; PubMed Central PMCID: PMC6254221.
Bidwell GL 3rd, Davis AN, Raucher D. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. J Control Release. 2009 Apr 2;135(1):2-10. doi: 10.1016/j.jconrel.2008.11.015. Epub 2008 Nov 28. PubMed PMID: 19095020.
Massodi I, Bidwell GL 3rd, Davis A, Tausend A, Credit K, Flessner M, Raucher D. Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP. Clin Exp Metastasis. 2009;26(3):251-60. doi: 10.1007/s10585-009-9237-z. Epub 2009 Jan 25. PubMed PMID: 19169893.
Raucher D, Massodi I, Bidwell GL. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide. Expert Opin Drug Deliv. 2008 Mar;5(3):353-69. doi: 10.1517/17425247.5.3.353. Review. PubMed PMID: 18318656.
Raucher D. Chapter 17: Application of laser tweezers to studies of membrane-cytoskeleton adhesion. Methods Cell Biol. 2008;89:451-66. doi: 10.1016/S0091-679X(08)00617-1. PubMed PMID: 19118686.
Massodi I, Raucher D. A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells. J Drug Target. 2007 Nov;15(9):611-22. doi: 10.1080/10611860701502780. PubMed PMID: 17968715.
Bidwell GL 3rd, Davis AN, Fokt I, Priebe W, Raucher D. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Invest New Drugs. 2007 Aug;25(4):313-26. doi: 10.1007/s10637-007-9053-8. Epub 2007 May 5. PubMed PMID: 17483874.
Bidwell GL 3rd, Fokt I, Priebe W, Raucher D. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochem Pharmacol. 2007 Mar 1;73(5):620-31. doi: 10.1016/j.bcp.2006.10.028. Epub 2006 Nov 10. PubMed PMID: 17161827.
Bidwell GL 3rd, Raucher D. Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc. Biochem Pharmacol. 2006 Jan 12;71(3):248-56. doi: 10.1016/j.bcp.2005.10.041. PubMed PMID: 16316634.
Massodi I, Bidwell GL 3rd, Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release. 2005 Nov 28;108(2-3):396-408. doi: 10.1016/j.jconrel.2005.08.007. Epub 2005 Sep 12. PubMed PMID: 16157413.
Bidwell GL 3rd, Raucher D. Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. Mol Cancer Ther. 2005 Jul;4(7):1076-85. doi: 10.1158/1535-7163.MCT-04-0253. PubMed PMID: 16020665.
Dreher MR, Raucher D, Balu N, Michael Colvin O, Ludeman SM, Chilkoti A. Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy. J Control Release. 2003 Aug 28;91(1-2):31-43. doi: 10.1016/s0168-3659(03)00216-5. PubMed PMID: 12932635.
Chilkoti A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev. 2002 Sep 13;54(5):613-30. doi: 10.1016/s0169-409x(02)00041-8. Review. PubMed PMID: 12204595.
Raucher D, Sheetz MP. Phospholipase C activation by anesthetics decreases membrane-cytoskeleton adhesion. J Cell Sci. 2001 Oct;114(Pt 20):3759-66. doi: 10.1242/jcs.114.20.3759. PubMed PMID: 11707527.
Raucher D, Stauffer T, Chen W, Shen K, Guo S, York JD, Sheetz MP, Meyer T. Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell. 2000 Jan 21;100(2):221-8. doi: 10.1016/s0092-8674(00)81560-3. PubMed PMID: 10660045.
Raucher D, Sheetz MP. Cell spreading and lamellipodial extension rate is regulated by membrane tension. J Cell Biol. 2000 Jan 10;148(1):127-36. doi: 10.1083/jcb.148.1.127. PubMed PMID: 10629223; PubMed Central PMCID: PMC2156205.
What would you like to do?